During angiogenesis, vascular endothelial growth factor regulate natural killer cell adhesion to tumor endothelium
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Localization of activated natural killer (A-NK) cells in the microvasculature of growing tumors is the result of recognition of the intracellular and vascular cell-adhesion molecules ICAM-1 and VCAM-1 on the tumor endothelium, mediated by lymphocyte function-associated protein LFA-1 and vascular lymphocyte function-associated protein VLA-4. In vitro and in vivo studies of A-NK cell adhesion to endothelial cells showed that vascular endothelial growth factor (VEGF) promotes adhesion, whereas basic fibroblast growth factor (bFGF) inhibits adhesion through the regulation of these molecules on tumor vasculature. Thus, some angiogenic factors may facilitate lymphocyte recognition of angiogenic vessels, whereas others may provide such vessels with a mechanism that protects them from cytotoxic lymphocytes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Angiogenic molecules present in the TME, such as VEGF (FIG. 1), can control the trafficking of immune cells to the tumour by altering the expression of adhesion molecules, including the integrin ligands intercellular adhesion molecule 1 (ICAM1) and vascular cell adhesion protein 1 (VCAM1), on endothelial cells (ECs) and immune cells10,14,15”
From Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges (2018) · cites this paper as [14]
Citations
Cites
Dvorak, H. F., Brown, L. F., Detmar, M. J., & Dvořàk, A. M. (1995) · Europe PMC (PubMed Central) · Cited by 3,115
Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
Brooks, P. C., Montgomery, A. M. P., Rosenfeld, M., Reisfeld, R. A., Hu, T., Klier, G., & Cheresh, D. A. (1994) · Cell · doi:10.1016/0092-8674(94)90007-8 · Cited by 2,262
Determinants of tumor blood flow: a review.
Jain, R. K. (1988) · PubMed · Cited by 1,379
Self-citationDefinition of Two Angiogenic Pathways by Distinct α v Integrins
Friedlander, M., Brooks, P. C., Shaffer, R. W., Kincaid, C. M., Varner, J. A., & Cheresh, D. A. (1995) · Science · doi:10.1126/science.270.5241.1500 · Cited by 1,321
Busch, H. (1969) · The American Journal of the Medical Sciences · doi:10.1097/00000441-196906000-00015 · Cited by 1,205
The implications of angiogenesis for the biology and therapy of cancer metastasis
Fidler, I. (1994) · Cell · doi:10.1016/0092-8674(94)90187-2 · Cited by 1,098
Leukocyte adhesion to endothelium in inflammation
Osborn, L. (1990) · Cell · doi:10.1016/0092-8674(90)90230-c · Cited by 865
Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1
Koch, A. E., Halloran, M. M., Haskell, C. J., Shah, M. R., & Polverini, P. J. (1995) · Nature · doi:10.1038/376517a0 · Cited by 600
Characterization of ICAM-2 and evidence for a third counter-receptor for LFA-1.
de Fougerolles, A. R., Stacker, S. A., Schwarting, R., & Springer, T. A. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.1.253 · Cited by 495
Yuan, F., Salehi, H. A., Boucher, Y., Vasthare, U. S., Tuma, R. F., & Jain, R. K. (1994) · PubMed · Cited by 463
Self-citation
Research works printed but not linked: 2
- Wu, N.Z., Klitzman, B., Dodge, R. & Dewhirst, M.W. iminished leukocyteendothelium interaction in tumor microvessels. Cancer Res. 52, 4265–4268 (1992).
- Dellian, M., Witwer, B.P., Salehi, H.A., Yuan, F. & Jain, R. uantitation and physiological characterization of angiogenic vessels in mice. Am. J. Pathol. 149, 59–71 (1996).
Cited by
The Biology of Vascular Endothelial Growth Factor
Ferrara, N., & Davis-Smyth, T. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.1.0287 · Cited by 4,330
Angiogenesis in health and disease
Carmeliet, P. (2003) · Nature Medicine · doi:10.1038/nm0603-653 · Cited by 4,276
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
Ferrara, N., Hillan, K. J., Gerber, H.-P., & Novotny, W. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1381 · Cited by 2,625
Molecular regulation of vessel maturation
Jain, R. K. (2003) · Nature Medicine · doi:10.1038/nm0603-685 · Cited by 2,529
Self-citationEnhancing cancer immunotherapy using antiangiogenics: opportunities and challenges
Fukumura, D., Kloepper, J., Amoozgar, Z., Duda, D. G., & Jain, R. K. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2018.29 · Cited by 2,027
Self-citationAsahara, T., Takahashi, T., Masuda, H., Kalka, C., Chen, D., Iwaguro, H., Inai, Y., Silver, M., & Isner, J. M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.14.3964 · Cited by 1,856
“VEGF has been shown to enhance vascular permeability (50 000 times more than histamine) (Senger et al., 1983; Keck et al., 1989) and modulate adhesion molecule expression on endothelium (Griffioen et al., 1996; Melder et al., 1996; Senger et al., 1996).”
BackgroundHypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions
Chen, Z., Han, F., Du, Y., Shi, H., & Zhou, W. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01332-8 · Cited by 1,612
Normalization of the Vasculature for Treatment of Cancer and Other Diseases
Goel, S., Duda, D. G., Xu, L., Munn, L. L., Boucher, Y., Fukumura, D., & Jain, R. K. (2011) · Physiological Reviews · doi:10.1152/physrev.00038.2010 · Cited by 1,605
Self-citationJain, R. K., di Tomaso, E., Duda, D. G., Loeffler, J. S., Sorensen, A. G., & Batchelor, T. T. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2175 · Cited by 1,405
Self-citationMolecular and biological properties of vascular endothelial growth factor
Ferrara, N. (1999) · Journal of Molecular Medicine · doi:10.1007/s001099900019 · Cited by 1,158
Cursiefen, C., Chen, L., Borges, L. P., Jackson, D. G., Cao, J., Radziejewski, C. H., D'Amore, P. A., Dana, M. R., Wiegand, S. J., & Streilein, J. W. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420465 · Cited by 1,059
Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies
Ambati, J., Ambati, B. K., Yoo, S. H., Ianchulev, S., & Adamis, A. P. (2003) · Survey of Ophthalmology · doi:10.1016/s0039-6257(03)00030-4 · Cited by 959
Takahashi, H., & Shibuya, M. (2005) · Clinical Science · doi:10.1042/cs20040370 · Cited by 953
Griffioen, A. W., & Molema, G. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01448-0 · Cited by 842
Delivery of molecular and cellular medicine to solid tumors
Jain, R. K. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.011 · Cited by 774
Self-citationVascular endothelial growth factor in eye disease
Penn, J. S., Madan, A., Caldwell, R. B., Bartoli, M., Caldwell, R. W., & Hartnett, M. E. (2008) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2008.05.001 · Cited by 762
Kim, I., Moon, S.-O., Hoon Kim, S., Jin Kim, H., Soon Koh, Y., & Young Koh, G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009705200 · Cited by 760
Role of vascular endothelial growth factor in the regulation of angiogenesis
Ferrara, N. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00610.x · Cited by 731
Yuan, F., Chen, Y., Dellian, M., Safabakhsh, N., Ferrara, N., & Jain, R. K. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14765 · Cited by 719
Self-citationThe two faces of IL-6 in the tumor microenvironment
Fisher, D. T., Appenheimer, M. M., & Evans, S. S. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.01.008 · Cited by 693
Transport of Molecules, Particles, and Cells in Solid Tumors
Jain, R. K. (1999) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.1.1.241 · Cited by 691
Self-citationImproving cancer immunotherapy using nanomedicines: progress, opportunities and challenges
Martin, J. D., Cabral, H., Stylianopoulos, T., & Jain, R. K. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0308-z · Cited by 682
Self-citationMosaic blood vessels in tumors: Frequency of cancer cells in contact with flowing blood
Chang, Y. S., di Tomaso, E., McDonald, D. M., Jones, R., Jain, R. K., & Munn, L. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.26.14608 · Cited by 671
Self-citationImproving immunotherapy outcomes with anti-angiogenic treatments and vice versa
Khan, K. A., & Kerbel, R. S. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2018.9 · Cited by 657
Dissecting tumour pathophysiology using intravital microscopy
Jain, R. K., Munn, L. L., & Fukumura, D. (2002) · Nature Reviews Cancer · doi:10.1038/nrc778 · Cited by 595
Self-citationConsensus guidelines for the use and interpretation of angiogenesis assays
Nowak-Sliwinska, P., Alitalo, K., Allen, E., Anisimov, A., Aplin, A. C., Auerbach, R., Augustin, H. G., Bates, D. O., van Beijnum, J. R., Bender, R. H. F., et al. (2018) · Angiogenesis · doi:10.1007/s10456-018-9613-x · Cited by 590
Self-citationTumor microenvironment abnormalities: Causes, consequences, and strategies to normalize
Fukumura, D., & Jain, R. K. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21187 · Cited by 584
Self-citationVEGF as a Therapeutic Target in Cancer
Ferrara, N. (2005) · Oncology · doi:10.1159/000088479 · Cited by 578
Stylianopoulos, T., Munn, L. L., & Jain, R. K. (2018) · Trends in Cancer · doi:10.1016/j.trecan.2018.02.005 · Cited by 563
Self-citationDetmar, M., Brown, L. F., Schön, M. P., Elicker, B. M., Velasco, P., Richard, L., Fukumura, D., Monsky, W., Claffey, K. P., & Jain, R. K. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00262.x · Cited by 550
Self-citationVascular Endothelial Growth Factor: Molecular and Biological Aspects
Ferrara, N. (1999) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-59953-8_1 · Cited by 533
Jain, R. K. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00131-9 · Cited by 529
Self-citationAn HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression
Palazon, A., Tyrakis, P. A., Macias, D., Veliça, P., Rundqvist, H., Fitzpatrick, S., Vojnovic, N., Phan, A. T., Loman, N., Hedenfalk, I., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.10.003 · Cited by 521
Pathological angiogenesis: mechanisms and therapeutic strategies
Dudley, A. C., & Griffioen, A. W. (2023) · Angiogenesis · doi:10.1007/s10456-023-09876-7 · Cited by 495
Heterogeneity of Endothelial Cells: Specific Markers
Garlanda, C., & Dejana, E. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.7.1193 · Cited by 483
Molecular Mechanisms and Future Implications of VEGF/VEGFR in Cancer Therapy
Patel, S. A., Nilsson, M. B., Le, X., Cascone, T., Jain, R. K., & Heymach, J. V. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-1366 · Cited by 481
Self-citationTargeting cytokine and chemokine signaling pathways for cancer therapy
Yi, M., Li, T., Niu, M., Zhang, H., Wu, Y., Wu, K., & Dai, Z. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01868-3 · Cited by 455
FUKUMURA, D., DUDA, D. G., MUNN, L. L., & JAIN, R. K. (2010) · Microcirculation · doi:10.1111/j.1549-8719.2010.00029.x · Cited by 451
Self-citationDiabetic Retinopathy: Vascular and Inflammatory Disease
Semeraro, F., Cancarini, A., dell’Omo, R., Rezzola, S., Romano, M. R., & Costagliola, C. (2015) · Journal of Diabetes Research · doi:10.1155/2015/582060 · Cited by 424
Ishida, S., Usui, T., Yamashiro, K., Kaji, Y., Amano, S., Ogura, Y., Hida, T., Oguchi, Y., Ambati, J., Miller, J. W., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20022027 · Cited by 421
Caldwell, C. C., Kojima, H., Lukashev, D., Armstrong, J., Farber, M., Apasov, S. G., & Sitkovsky, M. V. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.11.6140 · Cited by 420
Lymphangiogenesis and tumor metastasis: myth or reality?
Pepper, M. S. (2001) · PubMed · Cited by 418
Huinen, Z. R., Huijbers, E. J. M., van Beijnum, J. R., Nowak-Sliwinska, P., & Griffioen, A. W. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00496-y · Cited by 395
Joussen, A. M., Poulaki, V., Qin, W., Kirchhof, B., Mitsiades, N., Wiegand, S. J., Rudge, J., Yancopoulos, G. D., & Adamis, A. P. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64869-9 · Cited by 392
Saharinen, P., Tammela, T., Karkkainen, M. J., & Alitalo, K. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.05.003 · Cited by 391
VEGF164Is Proinflammatory in the Diabetic Retina
Ishida, S., Usui, T., Yamashiro, K., Kaji, Y., Ahmed, E., Carrasquillo, K. G., Amano, S., Hida, T., Oguchi, Y., & Adamis, A. P. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.02-0807 · Cited by 383
Jain, R. K., Safabakhsh, N., Sckell, A., Chen, Y., Jiang, P., Benjamin, L., Yuan, F., & Keshet, E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10820 · Cited by 374
Self-citationPlatelets and platelet adhesion support angiogenesis while preventing excessive hemorrhage
Kisucka, J., Butterfield, C. E., Duda, D. G., Eichenberger, S. C., Saffaripour, S., Ware, J., Ruggeri, Z. M., Jain, R. K., Folkman, J., & Wagner, D. D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510412103 · Cited by 361
Self-citationThe pathophysiologic role of VEGF in hematologic malignancies: therapeutic implications
Podar, K., & Anderson, K. C. (2005) · Blood · doi:10.1182/blood-2004-07-2909 · Cited by 343
Is diabetic retinopathy an inflammatory disease?
Adamis, A. P. (2002) · British Journal of Ophthalmology · doi:10.1136/bjo.86.4.363 · Cited by 341
THE ROLE OF VASCULAR ENDOTHELIAL GROWTH FACTOR IN OCULAR HEALTH AND DISEASE
ADAMIS, A. P., & SHIMA, D. T. (2005) · Retina · doi:10.1097/00006982-200502000-00001 · Cited by 334
Miyamoto, K., Khosrof, S., Bursell, S.-E., Moromizato, Y., Aiello, L. P., Ogura, Y., & Adamis, A. P. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65044-4 · Cited by 332
Monocyte/macrophage infiltration in tumors: modulators of angiogenesis
Dirkx, A. E. M., oude Egbrink, M. G. A., Wagstaff, J., & Griffioen, A. W. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0905495 · Cited by 326
Dirkx, A. E. M., Egbrink, M. G. A. O., Kuijpers, M. J. E., van der Niet, S. T., Heijnen, V. V. T., Steege, J. C. A. B.-T., Wagstaff, J., & Griffioen, A. W. (2003) · PubMed · Cited by 325
Kunstfeld, R., Hirakawa, S., Hong, Y.-K., Schacht, V., Lange-Asschenfeldt, B., Velasco, P., Lin, C., Fiebiger, E., Wei, X., Wu, Y., et al. (2004) · Blood · doi:10.1182/blood-2003-08-2964 · Cited by 311
Hypoxia-ischemia and retinal ganglion cell damage
Kaur, C. (2008) · Clinical Ophthalmology · doi:10.2147/opth.s3361 · Cited by 308
“VEGF enhances the adhesion of leukocytes to vascular walls and increases intercellular cell adhesion molecule-1(ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) expression in the brain and retina (Melder et al 1996; Lu et al 1999; Min et al 2005).”
BackgroundAngiogenic Growth Factor Messenger Ribonucleic Acids in Uterine Natural Killer Cells1
Li, X. F., Charnock-Jones, D. S., Zhang, E., Hiby, S., Malik, S., Day, K., Licence, D., Bowen, J. M., Gardner, L., King, A., et al. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.4.7418 · Cited by 301
Tsuzuki, Y., Fukumura, D., Oosthuyse, B., Koike, C., Carmeliet, P., & Jain, R. K. (2000) · PubMed · Cited by 301
Self-citationExtracellular membrane vesicles from tumor cells promote angiogenesis via sphingomyelin.
Kim, C. W., Lee, H. M., Lee, T. H., Kang, C., Kleinman, H. K., & Gho, Y. S. (2002) · PubMed · Cited by 301
Jain, R. K. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00306-6 · Cited by 298
Self-citationSimó, R., Sundstrom, J. M., & Antonetti, D. A. (2014) · Diabetes Care · doi:10.2337/dc13-2002 · Cited by 280
Delivery of molecular and cellular medicine to solid tumors
Jain, R. K. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00027-6 · Cited by 271
Self-citationDirkx, A. E. M., Egbrink, M. G. A. O., Castermans, K., van der Schaft, D. W. J., Thijssen, V. L. J. L., Dings, R. P. M., Kwee, L., Mayo, K. H., Wagstaff, J., Steege, J. C. A. B., et al. (2006) · The FASEB Journal · doi:10.1096/fj.05-4493com · Cited by 270
Vascular endothelial growth factor and endometriotic angiogenesis
McLaren, J. (2000) · Human Reproduction Update · doi:10.1093/humupd/6.1.45 · Cited by 269
“VEGF-A also increases the expression of vascular cell adhesion molecule-1 (VCAM-1) and intracellular adhesion molecule-1 (ICAM-1) in endothelial cells (Melder et al., 1996) and the promotion of monocyte chemotaxis (Clauss et al., 1990).”
BackgroundMechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis
Saaristo, A., Karpanen, T., & Alitalo, K. (2000) · Oncogene · doi:10.1038/sj.onc.1203969 · Cited by 264
“Integrins have also been shown to potentiate VEGF function in cell survival (see Ruoslahti, 1999) and VEGF has been found to upregulate cell adhesion molecules in vitro (Melder et al., 1996) and in vivo (Detmar et al., 1998).”
BackgroundMunn, L. L. (2017) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1370 · Cited by 257
Self-citationTumor angiogenesis and accessibility: Role of vascular endothelial growth factor
JAIN, R. (2002) · Seminars in Oncology · doi:10.1016/s0093-7754(02)70063-8 · Cited by 256
Self-citationProinflammatory functions of vascular endothelial growth factor in alloimmunity
Reinders, M. E. J., Sho, M., Izawa, A., Wang, P., Mukhopadhyay, D., Koss, K. E., Geehan, C. S., Luster, A. D., Sayegh, M. H., & Briscoe, D. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17712 · Cited by 251
Antiangiogenic properties of natural polyphenols from red wine and green tea
Oak, M.-H., El Bedoui, J., & Schini-Kerth, V. B. (2005) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2004.09.004 · Cited by 248
Harrod, C. G., Bendok, B. R., & Batjer, H. H. (2005) · Neurosurgery · doi:10.1227/01.neu.0000156644.45384.92 · Cited by 244
Effect of host microenvironment on the microcirculation of human colon adenocarcinoma.
Fukumura, D., Yuan, F., Monsky, W. L., Chen, Y., & Jain, R. K. (1997) · Europe PMC (PubMed Central) · Cited by 242
Self-citationVascular endothelial growth factor and diabetic complications
WIROSTKO, B., WONG, T., & SIMO, R. (2008) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2008.09.002 · Cited by 241
Mechanisms of action of flavopiridol
Sedlacek, H. H. (2001) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(00)00124-4 · Cited by 239
“Proangiogenic factors in tumors are known to induce downregulation of adhesion molecules such as ICAM1, ICAM-2, VCAM-1, E-selectin and CD34 on endothelial cells in the tumor vasculature and to induce resistance to inflammatory signals such as TNFa, IL-1 and IFNg [316–319].”
BackgroundVEGF increases retinal vascular ICAM-1 expression in vivo.
Lu, M., Perez, V. L., Ma, N., Miyamoto, K., Peng, H., Liao, J. K., & Adamis, A. P. (1999) · PubMed · Cited by 239
Diabetic macular edema: new concepts in patho-physiology and treatment
Zhang, X., Zeng, H., Bao, S., Wang, N., & Gillies, M. C. (2014) · Cell & Bioscience · doi:10.1186/2045-3701-4-27 · Cited by 230
Schlesinger, M., & Bendas, G. (2015) · International Journal of Cancer · doi:10.1002/ijc.28927 · Cited by 230
Fisher, D. T., Chen, Q., Skitzki, J. J., Muhitch, J. B., Zhou, L., Appenheimer, M. M., Vardam, T. D., Weis, E. L., Passanese, J., Wang, W.-C., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44952 · Cited by 229
Schwesinger, C., Yee, C., Rohan, R. M., Joussen, A. M., Fernandez, A., Meyer, T. N., Poulaki, V., Ma, J. J. K., Redmond, T. M., Liu, S., et al. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64063-1 · Cited by 225
A homing mechanism for bone marrow-derived progenitor cell recruitment to the neovasculature
Jin, H. (2006) · Journal of Clinical Investigation · doi:10.1172/jci24751 · Cited by 225
Garmy-Susini, B., Jin, H., Zhu, Y., Sung, R.-J., Hwang, R., & Varner, J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23445 · Cited by 216
Biology of Angiogenesis and Invasion in Glioma
Tate, M. C., & Aghi, M. K. (2009) · Neurotherapeutics · doi:10.1016/j.nurt.2009.04.001 · Cited by 213
Multifunctional Nanoemulsion Platform for Imaging Guided Therapy Evaluated in Experimental Cancer
Gianella, A., Jarzyna, P. A., Mani, V., Ramachandran, S., Calcagno, C., Tang, J., Kann, B., Dijk, W. J. R., Thijssen, V. L., Griffioen, A. W., et al. (2011) · ACS Nano · doi:10.1021/nn103336a · Cited by 212
Min, J.-K., Kim, Y.-M., Kim, S. W., Kwon, M.-C., Kong, Y.-Y., Hwang, I. K., Won, M. H., Rho, J., & Kwon, Y.-G. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.1.531 · Cited by 210
Verheul, H. M. W., Jorna, A. S., Hoekman, K., Broxterman, H. J., Gebbink, M. F. B. G., & Pinedo, H. M. (2000) · Blood · doi:10.1182/blood.v96.13.4216 · Cited by 210
Tumor and lymph node lymphangiogenesis—impact on cancer metastasis
Tobler, N. E., & Detmar, M. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.1105653 · Cited by 208
Manipulating angiogenesis in medicine
Carmeliet, P. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2003.01297.x · Cited by 207
Endothelial Dysfunction in Diabetic Retinopathy
Gui, F., You, Z., Fu, S., Wu, H., & Zhang, Y. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00591 · Cited by 207
Transscleral delivery of bioactive protein to the choroid and retina.
Ambati, J., Gragoudas, E. S., Miller, J. W., You, T., Miyamoto, K., Delori, F. C., & Adamis, A. P. (2000) · PubMed · Cited by 207
Role of nitric oxide in angiogenesis and microcirculation in tumors
Fukumura, D., & Jain, R. K. (1998) · Cancer and Metastasis Reviews · doi:10.1023/a:1005908805527 · Cited by 203
Self-citationBouzin, C., Brouet, A., De Vriese, J., DeWever, J., & Feron, O. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.3.1505 · Cited by 200
Delivery of Molecular and Cellular Medicine to Solid Tumors
Jain, R. K. (1997) · Microcirculation · doi:10.3109/10739689709148314 · Cited by 198
Self-citationHiratsuka, S., Goel, S., Kamoun, W. S., Maru, Y., Fukumura, D., Duda, D. G., & Jain, R. K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100446108 · Cited by 196
Self-citationGuenzi, E. (2001) · The EMBO Journal · doi:10.1093/emboj/20.20.5568 · Cited by 188
Delivery of molecular and cellular medicine to solid tumors
Jain, R. K. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00237-x · Cited by 186
Self-citationVEGF-mediated inflammation precedes angiogenesis in adult brain
CROLL, S. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.02.010 · Cited by 184
Huang, H., Langenkamp, E., Georganaki, M., Loskog, A., Fuchs, P. F., Dieterich, L. C., Kreuger, J., & Dimberg, A. (2015) · The FASEB Journal · doi:10.1096/fj.14-250985 · Cited by 182
Proescholdt, M. A., Jacobson, S., Tresser, N., Oldfield, E. H., & Merrill, M. J. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.10.914 · Cited by 182
Yonghua, Z., Kunlin, J., Ou Mao, X., & Greenberg, D. A. (2003) · The FASEB Journal · doi:10.1096/fj.02-0515com · Cited by 180
Fukumura, D., Yuan, F., Mitsuhiro, E. N. D. O., & Jain, R. K. (1997) · Europe PMC (PubMed Central) · Cited by 180
Self-citationVascular Targeting to Increase the Efficiency of Immune Checkpoint Blockade in Cancer
Georganaki, M., van Hooren, L., & Dimberg, A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03081 · Cited by 172
Metadata
- Authors
- Melder, R. J., Koenig, G. C., Witwer, B. P., Safabakhsh, N., Munn, L. L., & Jain, R. K.
- Affiliations
- Massachusetts General Hospital (US)
- Harvard University (US)
- Venue
- Nature Medicine
- Published
- 1996-09
- Volume
- 2
- Issue
- 9
- Pages
- 992-997
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W304295984
- Cited by
- 451
- References
- 39
- Citations by year
- 2026: 6 · 2025: 10 · 2024: 7 · 2023: 11 · 2022: 16 · 2021: 13 · 2020: 8 · 2019: 4 · 2018: 7 · 2017: 11 · 2016: 7 · 2015: 8 · 2014: 16 · 2013: 10 · 2012: 9
- FWCI
- 9.04
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (1f32ca061631-01a2)
- National Cancer Institute (F32-CA 61631, R35CA056591, R35-CA-56591)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
- Keywords
- natural killer cells, tumor endothelium, angiogenesis, vascular endothelial growth factor, basic fibroblast growth factor, cell adhesion, ICAM-1, VCAM-1, LFA-1, VLA-4, tumor vasculature, cytotoxic lymphocytes
- MeSH terms
- Animals, Cell Adhesion, Endothelium, Vascular, Humans, Lymphokines, Neoplasms, Experimental, Neovascularization, Pathologic, Tumor Cells, Cultured, Killer Cells, Lymphokine-Activated, Lymphocyte Function-Associated Antigen-1, Fibroblast Growth Factor 2, Endothelial Growth Factors, Mice, SCID, Intercellular Adhesion Molecule-1, P-Selectin, Vascular Cell Adhesion Molecule-1, E-Selectin, Vascular Endothelial Growth Factors, Vascular Endothelial Growth Factor A, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.